Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/1/1992
1.
Phase II Study of 131I-Labeled MOAB CC49 plus IL-1B in Patients with Colorectal Cancer (Summary Last Modified 06/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
UAC-2110
NCI-T91-0203C, T91-0203
Last Modified:
8/1/1992
2.
Phase II Study of IL-1B in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 08/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
WSU-C-98591
NCI-T91-0272D, T91-0272
Last Modified:
3/1/1989
3.
Phase I Study of the Pharmacokinetics, Tolerance to, and Hematologic Effect of Intravenous Interleukin-1-Beta in Adults Receiving 5-Fluorouracil for Advanced Colorectal Cancer (Summary Last Modified 03/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18
MSKCC-88119
NCI-V89-0008
Last Modified:
8/1/1992
4.
Phase I Study of IL-1B/CBDCA/VP-16 in Patients with Metastatic Cancer (Summary Last Modified 08/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18
NCI
SWOG-8940
SWOG-8940
Last Modified:
6/1/1997
5.
Phase IB Study of Interleukin-1-beta in Patients with Advanced Solid Tumors (Summary Last Modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Closed
18 and over
NCI
BRMP-8811A
NCI-90-C-62A, NCI-T89-0185N, T89-0185
Last Modified:
5/1/1992
6.
Phase I Study of Concomitant IL-1B and G-CSF Followed by Autologous Stem Cell Rescue from Myeloablative Chemotherapy with ICE (IFF/CBDCA/VP-16) in Patients with Refractory Intermediate-Grade non-Hodgkin's Lymphoma or Hodgkin's Disease (Summary Last Modified 05/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 to physiologic 64
NCI
BRMP-9101D
NCI-91-C-99D, NCI-T91-0021N, T91-0021
Last Modified:
2/1/1992
7.
Phase I Study of IL-1B/IL-2 in Patients with Metastatic Kidney Cancer, Colorectal Cancer, or Malignant Melanoma (Summary Last Modified 02/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
OSU-91HO154
NCI-B91-0021, B91-0021
Last Modified:
1/1/1994
8.
Phase I Pilot Study of IL-1B with and without CBDCA/CTX in Patients with Advanced Cancer (Summary Last Modified 01/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
MAYO-900302
NCI-T91-0157C, T91-0157
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute